#206 Billionaire
Zhu Yi
$12.8B
$-762M
(-5.6%)
CN
· Age 62
Source of wealth: Pharmaceuticals
Industry: healthcare
Residence: Chengdu
{
"bio": [
"Zhu Yi is the chairman of Biokin Pharmaceutical, a developer of drugs including anesthesia injections, cancer drugs as well as traditional Chinese medicine treatments.",
"The company went public in Shanghai in 2023, raising $136 million; it filed for a Hong Kong IPO in July 2024.",
"Biokin's U.S. subsidiary SystImmune signed in 2023 an $8.4 billion deal with Bristol Myers Squibb to jointly develop and commercialize a potential cancer treatment worldwide.",
"Zhu taught immunology and microbiology at West China University of Medical Sciences before striking out on his own."
],
"about": [
"Zhu has a master's in biology from Fudan University and a doctorate in management from Sichuan University."
]
}
Add a comment
Comments (0)
No comments yet. Be the first!